from the sentences were submitted to an acoustic analysisprocedure to yield measures.
Results: There were 28,648 patients who had outpatient thyroid surgery. A total of 19,487 patients had thyroid surgery for benign disease. A total of 8,909 patients had surgery for thyroid cancer. A total of 36.2% of surgeries were hemithyroidectomy and 44.5% were totals. A total of 1,333 of the thyroid cancer patients had a simultaneous neck dissection (5%). A total of 252 patients had neck dissection for thyroid cancer as a separate procedure. The average age was 48.7 (14.7) years and 71.8% of patients were female.
Conclusion: Thyroid surgery is increasingly being done outpatient. Improved surgical technique, anesthesia technique, hemostatic methods, and calcium management make this possible. This becomes a cost-effective way to manage both benign and malignant thyroid diseases. This is the largest series reporting outpatient thyroid surgery.
Head and Neck Surgery

Adenoviral Therapy in Radioresistant Squamous Cell Cancer
Sei-Young Lee, MD (presenter); Se-Heon Kim, MD Objective: Resistance to radiation is one of the main determinants of treatment outcome in the oral squamous cell carcinoma. We aim to identify that genetically modified adenovirus expressing RLX (Relaxin), which affects collagen metabolism, can effectively inhibit growth of the radioresistant oral SCC cell line.
Method:
Radioresistant oral SCC cell line was established. LDH assay was used to confirm the acquisition of radioresistance and cytotoxic effect of adenovirus. Tumor bearing nude mice were treated with expressing RLX adenovirus, dose dependently. Spread of adenovirus throughout the tumor mass was verified by immunohistochemistry.
Results: Radioresistant oral SCC cell line was more resistant to radiation therapy than mother oral SCC cell lines (p3 vs 45mm 3 vs 0mm 3 at Day 21). Also, the data shown that the minimum dose of adenovirus has the ability to kill the tumor cells (MOI = 5). In IHC data, the RLX expressing adenovirus eliminated collagens more effectively than non-RLX expressing adenovirus.
Conclusion: Oncolytic adenovirus can effectively inhibit growth of the radioresistance oral cancer cell line.
Head and Neck Surgery
Analysis of Normative Vagal and Recurrent laryngeal Nerve Electrophysiological Data
Phelan Eimear (presenter); Chris Slough, MD; Gregory W. Randolph, MD Objective: 1) Provide normative electrophysiological vagal and recurrent laryngeal nerve reference range values for intraoperative nerve monitoring in humans. 2) Highlight potential documentation implications of intraoperative nerve monitoring.
Method:
Consecutive monitored adult patients undergoing thyroid, parathyroid, and related neck surgery were included in this IRB approved study performed over an 8 month period. All patients had a preoperative and postoperative laryngeal examination to assess vocal cord function. Patients with an abnormal preoperative laryngeal examination were excluded.
Results:
In 64 patients the mean amplitude of the RLN (704mV, SD ± 512.7mV) was greater than the vagus nerve (524.5mV, SD± 388.0mV). The mean latency of the left and right RLN were 3.36ms (SD ± 0.92) and 3.45ms (SD ± 0.62) respectively. The mean latency of the left vagus was 7.48ms (SD ± 1.32), and the right vagus was 6.65ms (SD ± 1.28). The mean threshold intensity of stimulation of the right (0.41 mV, SD 0.20 mV) and left vagus (0.40 mV, SD 0.23 mV) were similar. The mean threshold of stimulation was higher in the right RLN (0.51 mV, SD 0.44). Amplitudes tended to be higher in females.
ORAL PRESENTATIONS
Conclusion: Normative vagal and RLN data is presented. The mean amplitude of the RLN was greater than the vagus nerve. The mean latency of the left vagus is longer than the right side. The threshold of stimulation is well below the standard stimulation current of 1 to 2 milliamps.
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AntiBiofilm Molecules on Tracheoesophageal Speaking Valves Adam Shakir (presenter); Grant Burgess; Nick Jakubovics; Robert Shields; Mohamed Reda El-Badawey, MBChB, FRCS Objective: The collection of biofilms on tracheo-esophageal speaking valves (TESV) detrimentally shortens their lifespan. A novel nontoxic enzyme (NucB) was discovered in the University of Newcastle and proved effective for dispersing marine biofilms. We propose to ascertain the effect of NucB on disrupting and removing mixed organism biofilms on TESVs.
Method:
We designed a case control study of ex-vivo TESVs, with build up of biofilms. Each TESV was divided into 2 equal parts. One half was treated with NucB and the other half with a nonactive control solution. Outcomes are measured by microscopy and culture of biofilm organisms.
Results: Ten TESVs were collected for our analysis in the microbiology laboratory. The more efficient our agent is in dispersing biofilms, the more organisms are released that can be cultured. With aerobic growth mediums, more organisms were cultured in 9 samples (90%, 95% CI 57-99%). With the use of growth mediums favouring fungal organisms, more organisms were cultured in 6 samples (60%, 95% CI 31-83%). The macroscopic appearances of TESVs were noticeably improved after treatment with NucB, with less visible contamination compared to control treated valves.
Conclusion: NucB, which is a nontoxic nuclease, was effective in the dispersion of the biofilms matrix collecting on TESVs. The treatment effect was greater for aerobic bacteria than fungal organisms. Our aim would be to use this agent to prolong the lifespan of TESVs and thus reduce costs.
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Association of DNA Copy Number and miRNA Expression in OSCC
Nicholas Anthony Serrano (presenter); Chang Xu; John Houck; Pei Wang; Wenhong Fan; Yan Liu; Pawadee Lohavanichbutr, MD Objective: Better understand possible mechanisms involved in the dysregulation unique to OSCC metastasis, we examined whether DNA copy number aberrations (CNAs) are associated with differential expression of miRNA that are found in OSCC metastasis.
Method: Tumor cells were laser capture microdissected from 17 nonmetastatic primary tumors and 20 metastatic lymph nodes. CNAs and gene expression profiles were previously determined using Affymetrix 250K Nsp I SNP Arrays and HU133 plus 2.0 expression profiles. MiRNAs were interrogated with Exiqon's Ready-to-use PCR Panels.
Results:
We found 155 miRNAs expressed in >80% of metastatic or nonmetastatic samples with 31 of them differentially expressed in metastatic tumor cells (FDR<0.4; 4 underexpressed) . We found the expression of 11 miRNAs to be significantly associated with their DNA copy numbers (p < 0.5) and 7 of these were among the differentially expressed miRNAs. Among these, miR-140-3p, miR-29c, and miR-29a showed a correlation between their expression and corresponding DNA copy number. These miRNAs were also associated with the down-regulation of their target genes in the MAP/ERK oncogenic pathway.
Conclusion:
Our results suggest that DNA copy number aberration may play a role in the dysregulation of miRNA in OSCC metastasis and that copy number driven miRNAs warrant further investigation.
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Bilateral iJV Sampling for Parathyroid Adenoma localization Evelyne Kalyoussef, MD (presenter); David H. Henick; Arie Rosen, MD; Chirag Patel, MD Objective: 1) Study the accuracy and utility of direct intraoperative internal jugular vein (IJV) sampling of parathyroid hormone (PTH) for localization of parathyroid adenoma. 2) Compare the accuracy of intraoperative IJV PTH sampling to that of preoperative Sestamibi scanning for lateralization.
Method:
A retrospective chart review of 51 consecutive neck explorations for primary hyperparathyroidism between 2007 and 2011. Direct bilateral IJV PTH sampling was performed prior to excision in all cases. Laterality based on IJV samples was compared with preoperative Sestamibi scans and operative findings.
Results: There were no complications associated with sampling. 50 patients had single parathyroid adenomas, and 1 patient had ipsilateral double adenomas. All IJV sampling value difference was considered lateralizing. In 39 cases, IJV sampling successfully predicted laterality of adenoma, yielding a positive predictive value (PPV) of 76.5%. Sestamibi scans correctly lateralized in 37 cases (72.5%), 12 (23.5%) were nonlocalizing, and 2 (3.9%) were incorrect. PPV of Sestamibi scanning was 95%. IJV sampling successfully predicted the laterality of adenoma in 9 (75%) of the nonlocalizing Sestamibi scans and in 1 of the 2 incorrect scans.
Conclusion:
In patients with unilateral parathyroid adenomas, intraoperative bilateral IJV PTH sampling is a safe means of determining laterality of adenomas with a positive predictive value of 76.5%. This can be a valuable adjunct in cases where preoperative localization studies were unsuccessful or inaccurate in localizing the adenoma.
